VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 783 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $309,883 | -54.3% | 9,133 | -57.4% | 0.01% | -70.0% |
Q1 2024 | $678,692 | +13.5% | 21,464 | +11.3% | 0.04% | +233.3% |
Q4 2023 | $597,873 | -87.5% | 19,280 | -89.2% | 0.01% | -77.8% |
Q3 2023 | $4,791,460 | +151.6% | 178,055 | +181.5% | 0.05% | +86.2% |
Q2 2023 | $1,904,337 | -50.8% | 63,246 | -47.2% | 0.03% | -64.2% |
Q1 2023 | $3,874,301 | +178.6% | 119,762 | +146.8% | 0.08% | +161.3% |
Q4 2022 | $1,390,727 | -69.8% | 48,525 | -74.6% | 0.03% | -63.5% |
Q3 2022 | $4,601,000 | +1662.8% | 190,761 | +2242.9% | 0.08% | +1114.3% |
Q4 2021 | $261,000 | -55.9% | 8,142 | -59.5% | 0.01% | -63.2% |
Q3 2021 | $592,000 | – | 20,079 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |